-
2
-
-
0037362655
-
Effect of pegylation on pharmaceuticals
-
DOI 10.1038/nrd1033
-
J.M. Harris, and R.B. Chess Effect of PEGylation on pharmaceuticals Nat. Rev. Drug Discov. 2 2003 214 221 (Pubitemid 37361666)
-
(2003)
Nature Reviews Drug Discovery
, vol.2
, Issue.3
, pp. 214-221
-
-
Milton Harris, J.1
Chess, R.B.2
-
3
-
-
68149163584
-
Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life
-
Y. Nojima, Y. Suzuki, K. Yoshida, F. Abe, T. Shiga, T. Takeuchi, A. Sugiyama, H. Shimizu, and A. Sato Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life Pharm. Res. 26 2009 2125 2132
-
(2009)
Pharm. Res.
, vol.26
, pp. 2125-2132
-
-
Nojima, Y.1
Suzuki, Y.2
Yoshida, K.3
Abe, F.4
Shiga, T.5
Takeuchi, T.6
Sugiyama, A.7
Shimizu, H.8
Sato, A.9
-
4
-
-
0035020761
-
Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-β-1a with preserved in vitro bioactivity
-
R.B. Pepinsky, D.J. LePage, A. Gill, A. Chakraborty, S. Vaidyanathan, M. Green, D.P. Baker, E. Whalley, P.S. Hochman, and P. Martin Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity J. Pharmacol. Exp. Ther. 297 2001 1059 1066 (Pubitemid 32472504)
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.297
, Issue.3
, pp. 1059-1066
-
-
Pepinsky, R.B.1
Lepage, D.J.2
Gill, A.3
Chakraborty, A.4
Vaidyanathan, S.5
Green, M.6
Baker, D.P.7
Whalley, E.8
Hochman, P.S.9
Martin, P.10
-
5
-
-
84858860729
-
PEGylated protein conjugates: A new class of therapeutics for the 21st century
-
F.M. Veronese, Birkhäuser Verlag Basel, Switzerland
-
R. Duncan, and F.M. Veronese PEGylated protein conjugates: a new class of therapeutics for the 21st century F.M. Veronese, PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Birkhäuser Verlag Basel, Switzerland 1 9
-
(2009)
PEGylated Protein Drugs: Basic Science and Clinical Applications
, pp. 1-9
-
-
Duncan, R.1
Veronese, F.M.2
-
6
-
-
78650185996
-
PEGylated inulin as long-circulating pharmaceutical carrier
-
G. Sun, X. Lin, Z. Wang, Y. Feng, D. Xu, and L. Shen PEGylated inulin as long-circulating pharmaceutical carrier J. Biomater. Sci. Polym. Ed. 22 2011 429 441
-
(2011)
J. Biomater. Sci. Polym. Ed.
, vol.22
, pp. 429-441
-
-
Sun, G.1
Lin, X.2
Wang, Z.3
Feng, Y.4
Xu, D.5
Shen, L.6
-
7
-
-
0035808059
-
Supramolecular-structured hydrogels showing a reversible phase transition by inclusion complexation between poly(ethylene glycol) grafted dextran and α-cyclodextrin
-
DOI 10.1021/ma0106649
-
K.M. Huh, T. Ooya, W.K. Lee, S. Sasaki, I.C. Kwon, S.Y. Jeong, and N. Yui Supramolecular-structured hydrogels showing a reversible phase transition by inclusion complexation between poly(ethylene glycol) grafted dextran and α-cyclodextrin Macromolecules 34 2001 8657 8662 (Pubitemid 34011391)
-
(2001)
Macromolecules
, vol.34
, Issue.25
, pp. 8657-8662
-
-
Huh, K.M.1
Ooya, T.2
Lee, W.K.3
Sasaki, S.4
Kwon, I.C.5
Jeong, S.Y.6
Yui, N.7
-
8
-
-
3042682776
-
PEGylated dextran as long-circulating pharmaceutical carrier
-
DOI 10.1163/156856204323046889
-
A.N. Lukyanov, R.M. Sawant, W.C. Hartner, and V.P. Torchilin PEGylated dextran as long-circulating pharmaceutical carrier J Biomater. Sci. Polym. Edn. 15 2004 621 630 (Pubitemid 38832585)
-
(2004)
Journal of Biomaterials Science, Polymer Edition
, vol.15
, Issue.5
, pp. 621-630
-
-
Lukyanov, A.N.1
Sawant, R.M.2
Hartner, W.C.3
Torchilin, V.P.4
-
9
-
-
23044444254
-
Application of ethoxylated inulin in water-blown polyurethane foams
-
DOI 10.1021/bm050006m
-
T.M. Rogge, C.V. Stevens, A. Vandamme, K. Booten, B. Levecke, C. D'Hooge, B. Haelterman, and J. Corthouts Application of ethoxylated inulin in water-blown polyurethane foams Biomacromolecules 6 2005 1992 1997 (Pubitemid 41056942)
-
(2005)
Biomacromolecules
, vol.6
, Issue.4
, pp. 1992-1997
-
-
Rogge, T.M.1
Stevens, C.V.2
Vandamme, A.3
Booten, K.4
Levecke, B.5
D'hooge, C.6
Haelterman, B.7
Corthouts, J.8
-
11
-
-
66349117714
-
Influence of sulfation on anti-myocardial ischemic activity of Ophiopogon japonicus polysaccharide
-
Q. Zheng, Y. Feng, D.S. Xu, X. Lin, and Y.Z. Chen Influence of sulfation on anti-myocardial ischemic activity of Ophiopogon japonicus polysaccharide J. Asian Nat. Prod. Res. 11 2009 306 321
-
(2009)
J. Asian Nat. Prod. Res.
, vol.11
, pp. 306-321
-
-
Zheng, Q.1
Feng, Y.2
Xu, D.S.3
Lin, X.4
Chen, Y.Z.5
-
12
-
-
21244483007
-
Determination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization
-
DOI 10.1016/j.ab.2005.04.025, PII S0003269705003210
-
X. Lin, D.S. Xu, Y. Feng, and L. Shen Determination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization Anal. Biochem. 342 2005 179 185 (Pubitemid 40884564)
-
(2005)
Analytical Biochemistry
, vol.342
, Issue.2
, pp. 179-185
-
-
Lin, X.1
Xu, D.-S.2
Feng, Y.3
Shen, L.4
-
13
-
-
77957269310
-
Poly(ethylene glycol)-Radix Ophiopogonis polysaccharide conjugates: Preparation, characterization, pharmacokinetics and in vitro bioactivity
-
X. Lin, S. Wang, Y. Jiang, Z.J. Wang, G.L. Sun, D.S. Xu, Y. Feng, and L. Shen Poly(ethylene glycol)-Radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity Eur. J. Pharm. Biopharm. 76 2010 230 237
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.76
, pp. 230-237
-
-
Lin, X.1
Wang, S.2
Jiang, Y.3
Wang, Z.J.4
Sun, G.L.5
Xu, D.S.6
Feng, Y.7
Shen, L.8
-
14
-
-
77954754871
-
A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats
-
X. Lin, Z. Wang, G. Sun, L. Shen, D. Xu, and Y. Feng A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats Biomed. Chromatogr. 24 2010 820 825
-
(2010)
Biomed. Chromatogr.
, vol.24
, pp. 820-825
-
-
Lin, X.1
Wang, Z.2
Sun, G.3
Shen, L.4
Xu, D.5
Feng, Y.6
-
15
-
-
17844363973
-
Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: Mechanisms of myocardial ischemic injury
-
DOI 10.1016/j.yjmcc.2005.02.019
-
M. Rodriguez, W.J. Cai, S. Kostin, B.R. Lucchesi, and J. Schaper Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanism of myocardial ischemic injury J. Mol. Cell. Cardiol. 38 2005 723 733 (Pubitemid 40591737)
-
(2005)
Journal of Molecular and Cellular Cardiology
, vol.38
, Issue.5
, pp. 723-733
-
-
Rodriguez, M.1
Cai, W.-J.2
Kostin, S.3
Lucchesi, B.R.4
Schaper, J.5
-
16
-
-
0347996095
-
Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits
-
DOI 10.1016/j.jconrel.2003.10.008
-
A.N. Lukyanov, W.C. Hartner, and V.P. Torchilin Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits J. Control. Release 94 2004 187 193 (Pubitemid 37542388)
-
(2004)
Journal of Controlled Release
, vol.94
, Issue.1
, pp. 187-193
-
-
Lukyanov, A.N.1
Hartner, W.C.2
Torchilin, V.P.3
-
17
-
-
24344501267
-
Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon japonicus
-
D.S. Xu, Y. Feng, X. Lin, H.L. Deng, J.N. Fang, and Q. Dong Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon japonicus Acta Pharmaceut. Sin. 40 2005 636 639 (Pubitemid 41260343)
-
(2005)
Yaoxue Xuebao
, vol.40
, Issue.7
, pp. 636-639
-
-
Xu, D.-S.1
Feng, Y.2
Lin, X.3
Deng, H.-L.4
Fang, J.-N.5
Dong, Q.6
-
18
-
-
0021333212
-
The mechanism of liposome accumulation in infarction
-
DOI 10.1016/0304-4165(84)90258-7
-
T.N. Palmer, V.J. Caride, M.A. Caldecourt, J. Twickler, and V. Abdullah The mechanism of liposome accumulation in infarction Biochim. Biophys. Acta 79 1984 363 368 (Pubitemid 14194902)
-
(1984)
Biochimica et Biophysica Acta - General Subjects
, vol.797
, Issue.3
, pp. 363-368
-
-
Palmer, T.N.1
Caride, V.J.2
Caldecourt, M.A.3
-
19
-
-
77957260557
-
The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)
-
F.M. Veronese, Birkhäuser Verlag Basel, Switzerland
-
J.K. Armstrong The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol) F.M. Veronese, PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Birkhäuser Verlag Basel, Switzerland 147 168
-
(2009)
PEGylated Protein Drugs: Basic Science and Clinical Applications
, pp. 147-168
-
-
Armstrong, J.K.1
-
20
-
-
33845938292
-
PEGylated proteins: Evaluation of their safety in the absence of definitive metabolism studies
-
DOI 10.1124/dmd.106.012419
-
R. Webster, E. Didier, P. Harris, N. Siegel, J. Stadler, L. Tilbury, and D. Smith PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies Drug Metab. Dispos. 35 2007 9 16 (Pubitemid 46036470)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.1
, pp. 9-16
-
-
Webster, R.1
Didier, E.2
Harris, P.3
Siegel, N.4
Stadler, J.5
Tilbury, L.6
Smith, D.7
-
21
-
-
78649238777
-
PEG and PEG conjugates toxicity: Towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals
-
F.M. Veronese, Birkhäuser Verlag Basel, Switzerland
-
R. Webster, V. Elliott, B.K. Park, D. Walker, M. Hankin, and P. Taupin PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals F.M. Veronese, PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Birkhäuser Verlag Basel, Switzerland 127 146
-
(2009)
PEGylated Protein Drugs: Basic Science and Clinical Applications
, pp. 127-146
-
-
Webster, R.1
Elliott, V.2
Park, B.K.3
Walker, D.4
Hankin, M.5
Taupin, P.6
-
22
-
-
0001349460
-
Clearance of PEGylated (40 kDa) interferon alfa-2a (PEGASYS) is primarily hepatic
-
M.W. Modi, J.S. Fulton, and D.K. Buckmann Clearance of PEGylated (40 kDa) interferon alfa-2a (PEGASYS) is primarily hepatic Hepatology 32 2000 371A
-
(2000)
Hepatology
, vol.32
-
-
Modi, M.W.1
Fulton, J.S.2
Buckmann, D.K.3
-
23
-
-
0031946518
-
Short communication: Renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins
-
DOI 10.1006/toxs.1997.2396
-
A. Bendele, J. Seely, C. Richey, G. Sennello, and G. Shopp Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins Toxicol. Sci. 42 1998 152 157 (Pubitemid 28211143)
-
(1998)
Toxicological Sciences
, vol.42
, Issue.2
, pp. 152-157
-
-
Bendele, A.1
Seely, J.2
Richey, C.3
Sennello, G.4
Shopp, G.5
-
24
-
-
77956468157
-
Mechanisms and strategies for targeting drugs to myocardial ischemic regions
-
G.L. Sun, and X. Lin Mechanisms and strategies for targeting drugs to myocardial ischemic regions Acta Pharm. Sin. 45 2010 827 832
-
(2010)
Acta Pharm. Sin.
, vol.45
, pp. 827-832
-
-
Sun, G.L.1
Lin, X.2
-
25
-
-
0029379702
-
Targeting of drugs and drug carriers within the cardiovascular system
-
V.P. Torchilin Targeting of drugs and drug carriers within the cardiovascular system Adv. Drug Deliv. Rev. 17 1995 75 101
-
(1995)
Adv. Drug Deliv. Rev.
, vol.17
, pp. 75-101
-
-
Torchilin, V.P.1
-
26
-
-
44249102128
-
Aiming for the heart: Targeted delivery of drugs to diseased cardiac tissue
-
DOI 10.1517/17425247.5.4.459
-
R.C. Scott, D. Crabbe, B. Krynska, R. Ansari, and M.F. Kiani Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue Expert Opin. Drug Deliv. 5 2008 459 470 (Pubitemid 351721724)
-
(2008)
Expert Opinion on Drug Delivery
, vol.5
, Issue.4
, pp. 459-470
-
-
Scott, R.C.1
Crabbe, D.2
Krynska, B.3
Ansari, R.4
Kiani, M.F.5
|